Rosen Law Firm said it continues to investigate potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). The announcement adds a separate investor-rights firm to scrutiny that began with Kahn Swick & Foti, LLC (KSF), whose inquiry followed a Scorpion Capital report alleging fraudulent billing, coercive business practices, unsafe organ transplantation, extortion, racketeering and organ trafficking. TransMedics and certain executives also face an ongoing securities class-action lawsuit alleging failures to disclose material information during the Class Period in violation of federal securities laws. TransMedics operates the Organ Care System and National OCS Program for patients with end-stage lung, heart and liver failure.